The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.

Headquartered in Northwood, Ohio, Namsa provides medical device testing, clinical research and regulatory consulting to medtech companies This acquisition is Namsa’s 10 th acquisition since becoming ...

Labcorp – a global life sciences and healthcare company – is set to close a Massachusetts lab and lay off dozens of workers.

Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancer MRD testing helps clinicians track a patient's risk ...

Nourish, a virtual nutrition provider, is launching a program that gives patients access to free cardiometabolic lab testing.  | Nourish Labs will integrate blood testing into personalized nutrition ...

Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...

Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality Results Today, Visby Medical announced two new relationships that will expand national access to the Visby ...

The rise of OTC and DTC diagnostics, driven by advancements in rapid and multiplex testing for home use, presents significant market opportunities. The shift towards consumer-accessible infectious ...

The survey of 152 clinicians also found that turnaround time and payor coverage are among the most important considerations for doctors when ordering cancer testing.

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Guardant Health (NASDAQ:GH) and its peers. The testing and diagnostics ...

There's a new option for testing and treating some of the most common sexually transmitted infections. China issues new Greenland warning to Trump administration Nikki Glaser trashes CBS News in ...

The study underscores the potential of home-based, self-collection testing to improve health outcomes for women from marginalized communities. By streamlining screening for multiple conditions in a ...